SCHEMBL2512465

SCHEMBL2512465

CCB(CC)CC.[HH].[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239458 0.95
SCHEMBL9581761 0.95
Water SCHEMBL3133097 0.90
SCHEMBL11129130 0.90
SCHEMBL27596874 0.89
SCHEMBL48883 0.89
Ammonia Solution, Strong SCHEMBL6551274 0.84
SCHEMBL476442 0.84
SCHEMBL8149703 0.84
Water SCHEMBL22582743 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2562158-A1 Processes for the preparation of n-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes Vertex Pharmaceuticals Incorporated (US) 2013-02-27 EP disclosed
EP-1603878-B1 PROCESSES FOR THE PREPARATION OF N-HETEROARYL-N-ARYL-AMINES BY REACTING AN N-ARYL CARBAMIC ACID ESTER WITH A HALO-HETEROARYL AND ANALOGOUS PROCESSES VERTEX PHARMA (US) 2013-01-02 EP disclosed
US-20120157684-A1 PROCESSES FOR THE FACILE SYNTHESIS OF DIARYL AMINES AND ANALOGUES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-21 US disclosed
US-8034950-B2 Processes for the facile synthesis of diaryl amines and analogues thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-10-11 US disclosed
CN-101723891-A Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes VERTEX PHARMA 2010-06-09 CN disclosed
CN-100579965-C Process for preparing N-heteroaryl-N-arylamines by reacting N-aryl carbamates with haloheteroaryls and analogous processes VERTEX PHARMA CO LTD 2010-01-13 CN disclosed
CN-101312939-A Heterocyclic cetp inhibitors BRISTOL MYERS SQUIBB CO (US) 2008-11-26 CN disclosed
US-20070173649-A1 Processes for the facile synthesis of diaryl amines and analogues thereof VERTEX PHARMACEUTICALS INCORPORATED 2007-07-26 US disclosed
US-7115746-B2 Processes for the facile synthesis of diaryl amines and analogues thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-10-03 US disclosed
CN-1761653-A Process for preparing N-heteroaryl-N-arylamines by reacting N-aryl carbamates with haloheteroaryls and analogous processes VERTEX PHARMA (US) 2006-04-19 CN disclosed
EP-1603878-A1 PROCESSES FOR THE PREPARATION OF N-HETEROARYL-N-ARYL-AMINES BY REACTING AN N-ARYL CARBAMIC ACID ESTER WITH A HALO-HETEROARYL AND ANALOGOUS PROCESSES Vertex Pharmaceuticals Incorporated (US) 2005-12-14 EP disclosed
US-20040230058-A1 Processes for the facile synthesis of diaryl amines and analogues thereof VERTEX PHARMACEUTICALS INCORPORATED 2004-11-18 US disclosed
WO-2004072038-A1 PROCESSES FOR THE PREPARATION OF N-HETEROARYL-N-ARYL-AMINES BY REACTING AN N-ARYL CARBAMIC ACID ESTER WITH A HALO-HETEROARYL AND ANALOGOUS PROCESSES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-08-26 WO disclosed